这本前几天刚被SCI收录的国产刊,一审平均24天

今天给大家介绍一本国产英文期刊Journal of Clinical and Translational Hepatology《临床与转化肝脏病学杂志》,该期刊主要分类领域是肝病研究,期刊简称JCTH

喜  讯

GOOD NEWS

JCTH正式被SCIE收录

2020年11月10日,出版社收到Web of Science评审组的邮件通知:Journal of Clinical and Translational Hepatology(JCTH)已经通过专家评审,被正式收入Science Citation Index Expanded (SCIE)数据库及相关指数体系,具体还包括Current Contents / Clinical Medicine, Essential Science Indicators (ESI)和Journal Citation Reports Science(图1)。根据通知,JCTH自2017年12月30日之后发表的所有论文都将被收录。预计明年6月将获得首个影响因子,这标志着该刊经过近7年的精心培育,获得了学术界和出版界的认可,从此迈入国际一流学术期刊行列。

图1. Web of Science通知邮件

期刊简介

关于此刊的具体情况,大家可以看看:

截图自JCTH官网

Journal of Clinical and Translational Hepatology (JCTH,《临床与转化肝脏病杂志》,pISSN: 2225-0719, eISSN: 2310-8819)是由重庆医科大学附属第二医院主办,Xia & He Publishing Inc.(华誉出版社)出版的英文学术期刊,其主要兴趣领域是肝病方向。JCTH创刊于2013年7月,目前总共发表论文360余篇,2015年7月被PubMed Central及PubMed收录,2020年5月被Scopus收录,2020年11月10日被SCIE收录。

根据WoS核心库检索数据(至20201110日),JCTH2018-2019年共发文111篇(Article和Review),上述111篇文章在2020年(至20201110日)共计被引用319次,如果代入影响因子计算公式,可估算出JCTH即时因子:319/111=2.873。因此,预测2021年6月份公布的IF将超3分,估计在3.5分左右,甚至有机会冲击4分。就目前的发展情况来看,JCTH进入SCI后的发展潜力很大,未来可期!

JCTH拥有来自24个国家和地区共计130余名资深肝病领域专家组成的编委队伍,以及来自44个国家和地区的400余名审稿专家团队。JCTH目前为季刊,分别于每年3、6、9、12月出刊,2019年从投稿到第一次审稿决定的平均时间为24天,从接受到在线发表的平均时间为23天,2020年因为COVID-19相关文章快速处理等原因,上述平均时长显著提升。

JCTH第8卷3期大事记

2020年6月7日

JCTH第8卷3期第一篇文章接受

2020年7月3日

JCTH第8卷3期第一篇文章online

2020年9月21日

JCTH第8卷3期16篇文章全部online

2020年9月28日

JCTH第8卷3期正式出版

JCTH第8卷3期文章预览

Original Article|Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease

Amelia Fierro-Fine, Leana Guerin, Hasan Hicsasmaz, Kyle E. Brown

Doi: 10.14218/JCTH.2020.00022

Original Article|Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver Failure

Caiyun Nie, Lei Zhang, Xiaobing Chen, Ying Li, Fushuang Ha, Hua Liu, Tao Han

Doi: 10.14218/JCTH.2020.00045

Original Article|Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study

Lin Fu, Jun Fei, Shen Xu, Hui-Xian Xiang, Ying Xiang, Biao Hu, Meng-Die Li, Fang-Fang Liu, Ying Li, Xiu-Yong Li, Hui Zhao, De-Xiang Xu

Doi: 10.14218/JCTH.2020.00043

Original Article|Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis

Huiying Rao, Xingxiang Yang, Youwen Tan, Qin Ning, Daokun Yang, Jiefei Wang, Yongfeng Yang, Sujun Zheng, Dongliang Yang, Jinlin Hou, Qing Xie, Caiyan Zhao, Lunli Zhang, Xiaorong Mao, Tong Sun, Lang Bai, Fuchun Zhang, Jinglan Jin, Yingren Zhao, Maorong Wang, Wen Xie, Yingjie Ma, Jun Quan, Xuebing Yan, Ping An, Feng Lin, Jidong Jia, Xiaoxuan Hu, Zuojiong Gong, Jie Wu, Yongping Chen, Zhansheng Jia, Minghua Lin, Guiqiang Wang, Yueyong Zhu, Yingjun Zhang, Hongming Xie, Lin Luo, Qingyun Ren, Rui Huang, Lai Wei

Doi: 10.14218/JCTH.2020.000315

Original Article|Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy

Chencheng Xie, Yong-Fang Kuo, Ashwani K. Singal

Doi: 10.14218/JCTH.2020.00032

Original Article|Efficacy and Safety of Glecaprevir/Pibrentasvir for Chronic Hepatitis C Patients: A Systematic Review and Meta-analysis

Hong-Qin Xu, Chun-Guang Wang, Peng Xiao, Yan-Hang Gao

Doi: 10.14218/JCTH.2020.00047

Original Article|Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis

Hong-lian Gui, Chang-qing Zhao, Yan Wang, Hong-tu Gu, Wei-jing Wang, Wei Cai, Qing Guo, Shi-san Bao, Lie-ming Xu, Qing Xie

Doi: 10.14218/JCTH.2020.000048

Original Article|Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy

Chuan Li, Kang Chen, Xu Liu, Hao-Tian Liu, Xiu-Mei Liang, Guang-Lan Liang, Shao-Tong Tang, Rong-Rui Huo, Liang Ma, Bang-Be Xiang, Jian-Hong Zhong, Le-Qun Li

Doi: 10.14218/JCTH.2020.00021

Original Article|Predicting Infiltrative Hepatocellular Carcinoma Patient Outcome Post-TACE: MR Bias Field Correction Effect on 3D-quantitative Image Analysis

Cuihong Liu, Susanne Smolka, Xenophon Papademetris, Duc Do Minh, Geliang Gan, Yanhong Deng, MingDe Lin, Julius Chapiro, Ximing Wang, Christos Georgiades, Kelvin Hong

Doi: 10.14218/JCTH.2020.00054

Original Article|Employment and Patient Satisfaction after Liver Transplantation

Christopher Cao, Dina Halegoua-DeMarzio, Shady Guirguis, Crystal Chen, Jonathan M. Fenkel, Steven Herrine

Doi: 10.14218/JCTH.2020.00010

Review Article|Antihepatic Fibrosis Drugs in Clinical Trials

Yue-Cheng Guo, Lun-Gen Lu

Doi: 10.14218/JCTH.2020.00023

Review Article|HEV and HBV Dual Infection: A Review

Myra Nasir, George Y. Wu

Doi: 10.14218/JCTH.2020.00030

Review Article|Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents

Jenny Hong, Robert C. Wright, Nilu Partovi, Eric M. Yoshida, Trana Hussaini

Doi: 10.14218/JCTH.2020.00034

Review Article|Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review

Sheena Mago, George Y. Wu 

Doi: 10.14218/JCTH.2020.00036

Review Article|Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications

Tomislav Kizivat, Ivana Maric, Dunja Mudri, Ines Bilic Curcic, Dragan Primorac, Martina Smolic

Doi: 10.14218/JCTH.2020.00027

Letter to the editor|Revised Nomenclature for Fatty Liver Disease: Cutting through the Confusion

Khalid Alsawat, Almoutaz Hashim, Mohamed Alboraie, Yasser Fouad

Doi: 10.14218/JCTH.2020.00049

声明:本文转自“华誉学术”,文章转载只为学术传播,如涉及侵权问题,请联系我们, 我们将及时修改或删除。

沃斯(WOSCI)由耶鲁大学博士团队匠心打造,专注最新科学动态并提供各类科研学术指导,包括:前沿科学新闻、出版信息、期刊解析、论文写作技巧、学术讲座、论文润色等。

你可能感兴趣的:(这本前几天刚被SCI收录的国产刊,一审平均24天)